🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to compare the progression-free surviv...
Status
Suspended
Location
Bond Clinic, P.A.
Start Date
2022-05-12
Trial ID
NCT05378763
Treatments Being Tested
The main objective of this study is to determine the maximum tolerated dose...
Status
Completed
Location
Seoul National University Hospital
Start Date
2011-06
Trial ID
NCT01455584
Treatments Being Tested
This is a Phase 2, open-label, multicenter study to evaluate the efficacy a...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2019-07-30
Trial ID
NCT04044170
Treatments Being Tested
This is a Phase 1b, open-label, multicenter study to determine the Maximum ...
Status
Terminated
Location
Pacific Cancer Medical Center, Inc.
Start Date
2018-07-13
Trial ID
NCT03429101
Treatments Being Tested
The purpose of the study is to evaluate the effect of multiple-doses of itr...
Status
Completed
Location
Celerion, Phoenix clinical facility
Start Date
2021-04-08
Trial ID
NCT04981704
Treatments Being Tested
The purpose of this study is to establish the dose regimen and evaluate the...
Status
Completed
Location
Clearview Cancer Center
Start Date
2016-02-22
Trial ID
NCT02659514
Treatments Being Tested
This is a Phase 2, open-label, multi-center study to evaluate the efficacy ...
Status
Terminated
Location
Mayo Clinic Hospital
Start Date
2017-10-11
Trial ID
NCT03318939
Treatments Being Tested
In this trial, treatment efficacy and safety of Poziotinib will be assessed...
Status
Completed
Location
Korean Association for the Study of Targeted Therapy
Start Date
2016-10
Trial ID
NCT02979821
Treatments Being Tested
This is a Phase 2, open-label, multicenter study whose principal objectives...
Status
Terminated
Location
Pacific Shores Medical Group
Start Date
2019-12-23
Trial ID
NCT04172597
Treatments Being Tested
A Phase 1/2, open-label, multicenter study to determine dose, tolerability,...
Status
Terminated
Location
National Cancer Center East
Start Date
2020-06-23
Trial ID
NCT04402008